The Cancer Biopsy Market is projected to witness significant growth from 2025 to 2033, driven by the increasing incidence of cancer. Valued at approximately USD 32.9 billion in 2025, the market is expected to surge to USD 62.7 billion by 2033, reflecting a strong compound annual growth rate (CAGR) of 8.4% over the ten-year period.